Vervaardiging van geneesmiddelen

NACE 21201

Active companies, 5-year failure rate, regional split and recent bankruptcies for this NACE sector.

1,028 active companies with this primary NACE

Active companies1,028

Bankruptcies (5y)5

Failure rate0.49%

Regions covered4

Provinces covered11

Bankruptcies and the failure rate are attributed by each company's current primary NACE, not the NACE at the time of bankruptcy (which the gazette does not record).

Sector key figures

fiscal year 2024 · median over 46 filed annual accounts (NACE division 21)

Median solvency

46.9%

Median equity

€108k

Median net result

€-1k

Annual accounts in sample

Source: NBB annual accounts, all schema types combined. Medians computed internally.

Regional split

by region

Vlaanderen 64 · 45.1%

Wallonië 51 · 35.9%

Brussel 24 · 16.9%

Unknown 3 · 2.1%

Recent bankruptcies in this sector

Date	Company
24-04-2026	San'Up BE 0693.818.729
27-10-2025	Quantoom Biosciences BE 0744.643.858
02-09-2025	EXOTHERA BE 0744.643.660
14-06-2024	Mithra Pharmaceuticals BE 0466.526.646
14-06-2024	GRAFTYS BE 0676.661.805

Geographic distribution

by province · based on the establishment address

West Flanders WVL 5

East Flanders OVL 17

Antwerp ANT 28

Flemish Brabant VLB 4

Limburg LIM 10

Brussels BRU 24

Hainaut HAI 11

Walloon Brabant WBR 16

Namur NAM 3

Liège LIE 17

Luxembourg LUX 4

fewer moremax 28